Fang Tang

发表

Small Nucleolar RNA 71A Promotes Lung Cancer Cell Proliferation, Migration and Invasion via MAPK/ERK Pathway

Yuan Luo, N. Zhang, C. Xie, 2019, Journal of Cancer.

SBI0206965, a novel inhibitor of Ulk1, suppresses non-small cell lung cancer cell growth by modulating both autophagy and apoptosis pathways.

Junhong Zhang, C. Xie, Shaoxing Sun, 2017, Oncology reports.

ATG7 promotes the tumorigenesis of lung cancer but might be dispensable for prognosis predication: a clinicopathologic study

C. Xie, Zhihao Wang, Shaoxing Sun, 2016, OncoTargets and therapy.

Tumor-derived exosomes: the emerging orchestrators in melanoma.

Yufang Tan, Honghao Yu, Qi Zhang, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy

C. Xie, Y. Gong, Fajian He, 2022, Frontiers in Immunology.

MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity

Yuan Luo, Yu Xiao, Yingming Sun, 2020, International journal of biological sciences.

HDAC6-mediated EGFR stabilization and activation restrict cell response to sorafenib in non-small cell lung cancer cells

C. Xie, Zhihao Wang, P. Hu, 2016, Medical Oncology.

HDAC6 promotes cell proliferation and confers resistance to temozolomide in glioblastoma.

Yingying Zhang, Wanhong Liu, Xiaohua He, 2016, Cancer letters.

FePt-Cys nanoparticles induce ROS-dependent cell toxicity, and enhance chemo-radiation sensitivity of NSCLC cells in vivo and in vitro.

Yuan Luo, Lei Zhang, Yu Xiao, 2018, Cancer letters.

HDAC6 promotes cell proliferation and confers resistance to gefitinib in lung adenocarcinoma.

Ying Wang, C. Xie, Zhihao Wang, 2016, Oncology reports.

β-catenin decreases acquired TRAIL resistance in non-small-cell lung cancer cells by regulating the redistribution of death receptors.

Yu Xiao, Xuefeng Liu, Yingming Sun, 2018, International journal of oncology.